The global functional food and beverage market is projected to reach $438 billion in 2026, with oral pouches and alternative caffeine delivery formats driving growth. Doseology Sciences launched caffeine-based energy pouches under its Feed That Brain brand, while Kraft Heinz introduced the HEINZ KegChup, Tilray Brands expanded spirits distribution in Illinois, Cronos Group launched Lord Jones cannabis in Israel, and USANA Health Sciences reported strong 2025 sales with positive 2026 guidance.

The global consumer healthcare market is experiencing a structural shift where regulatory compliance and FDA approval have become critical competitive advantages. Major companies including Philip Morris, Celsius Holdings, USANA Health Sciences, and Medifast are advancing strategic initiatives focused on regulatory readiness, product integration, and market expansion. Doseology Sciences has partnered with McKinney Regulatory Science Advisors to strengthen its FDA pathway for oral pouch products.

The global women's health and beauty supplements market is experiencing robust growth, expanding from USD 62.42 billion in 2024 to USD 66.38 billion in 2025, with projections to reach USD 91.42 billion by 2030 at a CAGR of 6.56%. Key growth drivers include ingredient innovation (collagen, probiotics, adaptogens), format evolution (gummies, powders), direct-to-consumer engagement, and regional localization strategies. The market is characterized by a mixed ecosystem of legacy manufacturers, emerging digital brands, and ingredient innovators leveraging strategic partnerships for competitive advantage.

U.S. stock futures rose on Friday after Thursday's market decline, with corporate earnings providing mixed results. Key focus was on potential trade discussions between U.S. and China, and market expectations of potential Federal Reserve interest rate cuts.

Xencor shares surged 10.5% after the company announced a secondary stock offering to raise $175 million. The company plans to use the funds to support its pipeline development. However, earnings and revenue expectations for the upcoming quarter are negative, which may impact the stock's future performance.

Taking a multivitamin once a day has long been considered a path to better health, but a new study refutes that widely held belief. A study published in JAMA Network Open on Wednesday revealed that after tracking nearly 400,000 healthy adults for over 20 years, researchers found no link between regular multivitamin use and a lower risk of death, according to the National Institutes of Health. The study was led by researchers at the National Institutes of Health's National Cancer Institute. Also Read: Healthcare Advocates United: A Push For Congress To Recognize CBD As Dietary Supplements “The analysis showed ...Full story available on Benzinga.com

USNA vs. ZTS: Which Stock Is the Better Value Option?

USNA vs. ZTS: Which Stock Is the Better Value Option?

USNA vs. STVN: Which Stock Is the Better Value Option?

USNA vs. STVN: Which Stock Is the Better Value Option?

USANA Health (USNA) delivered earnings and revenue surprises of 24.64% and 2.03%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Indivior (INDV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.